Company: Skye Bioscience, Inc. (NYSE: SKYE) is a clinical stage biopharmaceutical company that focuses on developing molecules that modulate G protein-coupled receptors (“GPCRs”) to treat obesity, overweight, and metabolic diseases. The Company's lead product candidate is nimacimab. https://mma.prnewswire.com/media/1321386/Robbins_LLP_Logo.jpg What is the class period? November 4, 2024 – October 3, 2025 What is the case about?Robbins […]

Performance-driven, ultra-compact, fiber-ready, and OT-optimized models BEC Technologies, a leading developer and manufacturer of 4G/LTE and 5G Wireless WAN connectivity solutions, today announced the MX-220 5G Series, a family of compact 5G industrial routers that deliver secure, always-on connectivity for mission-critical edge applications across utilities, service providers, industrial operations, and enterprise customers. The series includes

Parents and advocates projected “Stop [AI Czar David] Sacks' AI Preemption”, “AI Amnesty Harms Kids”, and “Don't Let AI Buy the Government” Protest comes ahead of House child safety hearing and negotiations over adding dangerous AI provisions to the year-end defense bill ** PICTURES AVAILABLE HERE ** WASHINGTON, Dec. 02, 2025 (GLOBE NEWSWIRE) — Bereaved

Bereaved Parents, Advocates, & Heat Initiative Stage DC Protest Against AI Preemption Amid Defense Bill Negotiations GlobeNewswire December 02, 2025 Parents and advocates projected “Stop [AI Czar David] Sacks' AI Preemption”, “AI Amnesty Harms Kids”, and “Don't Let AI Buy the Government” Protest comes ahead of House child safety hearing and negotiations over adding dangerous

New York, New York–(Newsfile Corp. – December 2, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Primo Water Corporation (NYSE: PRMW) between June 17, 2024 and November 8, 2024, both dates inclusive, and/or (ii) purchasers of common stock of Primo Brands Corporation (NYSE: PRMB) between November

New York, New York–(Newsfile Corp. – December 2, 2025) – Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Synopsys, Inc. (NASDAQ: SNPS) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations of the

New York, New York–(Newsfile Corp. – December 2, 2025) – Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in MoonLake, you are encouraged to

New York, New York–(Newsfile Corp. – December 2, 2025) – Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) and certain of the Company’s senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal

New York, New York–(Newsfile Corp. – December 2, 2025) – Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CarMax, Inc. (NYSE: KMX) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations of the

New York, New York–(Newsfile Corp. – December 2, 2025) – Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against James Hardie Industries plc (NYSE: JHX) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations